Get started
EDWARDS LIFESCIENCESEDWARDS LIFESCIENCESEDWARDS LIFESCIENCES

EDWARDS LIFESCIENCES

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

EWL chart


Full chart

Key facts today


Goldman Sachs has raised its price target on Edwards Lifesciences to $89 from $85 while maintaining a 'Buy' rating.
Analyze the impactAnalyze the impact

EWL upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪36.45 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
28.91
Basic EPS (TTM)
2.37 EUR
Net income (FY)
‪844.84 M‬ EUR
Revenue (FY)
‪5.25 B‬ EUR
Shares float
‪574.31 M‬
Beta (1Y)
0.47

Employees


Employees (FY)
‪15.8 K‬
Change (1Y)
‪−4 K‬ −20.20%
Revenue / Employee (1Y)
‪332.56 K‬ EUR
Net income / Employee (1Y)
‪85.65 K‬ EUR

About Edwards Lifesciences Corporation


Sector
Health Technology
Industry
Medical Specialties
CEO
Bernard J. Zovighian
Website
edwards.com
Headquarters
Irvine
Founded
1958
FIGI
BBG000BT03P9
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

EWL news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

EWL highest yielding bonds


US28176EAD0
EDWARDS LIFE. 18/28
Yield to maturity
4.94%
Maturity date
Jun 15, 2028

See all EWL bonds 


Check out other big names from the same industry as EWL.

Frequently Asked Questions


The current price of EWL is 62.50 EUR — it has decreased by −0.064% in the past 24 hours. Watch EDWARDS LIFESCIENCES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange EDWARDS LIFESCIENCES stocks are traded under the ticker EWL.
EWL stock has fallen by −0.65% compared to the previous week, the month change is a −5.06% fall, over the last year EDWARDS LIFESCIENCES has showed a −23.47% decrease.
We've gathered analysts' opinions on EDWARDS LIFESCIENCES future price: according to them, EWL price has a max estimate of 79.04 EUR and a min estimate of 53.57 EUR. Watch EWL chart and read a more detailed EDWARDS LIFESCIENCES stock forecast: see what analysts think of EDWARDS LIFESCIENCES and suggest that you do with its stocks.
EWL reached its all-time high on Apr 21, 2022 with the price of 119.10 EUR, and its all-time low was 1.53 EUR and was reached on Jul 24, 2002. View more price dynamics on EWL chart.
See other stocks reaching their highest and lowest prices.
EWL stock is 0.064% volatile and has beta coefficient of 0.47. Track EDWARDS LIFESCIENCES stock price on the chart and check out the list of the most volatile stocks — is EDWARDS LIFESCIENCES there?
Today EDWARDS LIFESCIENCES has the market capitalization of ‪36.25 B‬, it has increased by 2.77% over the last week.
Yes, you can track EDWARDS LIFESCIENCES financials in yearly and quarterly reports right on TradingView.
EDWARDS LIFESCIENCES is going to release the next earnings report on Jul 24, 2025. Keep track of upcoming events with our Earnings Calendar.
EWL earnings for the last quarter are 0.59 EUR per share, whereas the estimation was 0.55 EUR resulting in a 7.30% surprise. The estimated earnings for the next quarter are 0.55 EUR per share. See more details about EDWARDS LIFESCIENCES earnings.
EDWARDS LIFESCIENCES revenue for the last quarter amounts to ‪1.31 B‬ EUR, despite the estimated figure of ‪1.29 B‬ EUR. In the next quarter, revenue is expected to reach ‪1.31 B‬ EUR.
EWL net income for the last quarter is ‪330.91 M‬ EUR, while the quarter before that showed ‪372.48 M‬ EUR of net income which accounts for −11.16% change. Track more EDWARDS LIFESCIENCES financial stats to get the full picture.
No, EWL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 25, 2025, the company has ‪15.8 K‬ employees. See our rating of the largest employees — is EDWARDS LIFESCIENCES on this list?
Like other stocks, EWL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EDWARDS LIFESCIENCES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EDWARDS LIFESCIENCES technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EDWARDS LIFESCIENCES stock shows the sell signal. See more of EDWARDS LIFESCIENCES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.